COVI-VAC

candidate vaccine against COVID-19
Thing general Q107229181
Press Enter · cited answer in seconds

COVI-VAC

Summary

COVI-VAC ranks in the top 2% of general entities by monthly Wikipedia readership (8 views/month).[1]

Key Facts

  • COVI-VAC's developer is recorded as Codagenix (United States)[2].
  • COVI-VAC's subclass of is recorded as COVID-19 vaccine[3].
  • COVI-VAC's subclass of is recorded as vaccine[4].
  • COVI-VAC's route of administration is recorded as nasal administration[5].

Why It Matters

COVI-VAC ranks in the top 2% of general entities by monthly Wikipedia readership (8 views/month).[1] COVI-VAC has Wikipedia articles in 5 language editions, a strong signal of global cultural recognition.[6]

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). COVI-VAC. Retrieved April 10, 2026, from https://4ort.xyz/entity/covi-vac
MLA “COVI-VAC.” 4ort.xyz Knowledge Graph, 4ort.xyz, 10 Apr. 2026, https://4ort.xyz/entity/covi-vac.
BibTeX @misc{4ortxyz_covi-vac_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{COVI-VAC}}, year = {2026}, url = {https://4ort.xyz/entity/covi-vac}, note = {Accessed: 2026-04-10}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): COVI-VAC — https://4ort.xyz/entity/covi-vac (retrieved 2026-04-10)

Canonical URL: https://4ort.xyz/entity/covi-vac · Last refreshed: